Abstract
Dementia is a debilitating condition characterised by global loss of cognitive and intellectual functioning, which reduces social and occupational performance. This population frequently presents with medical co-morbidities such as hypertension, cardiovascular disease and diabetes. The CONSORT statement outlines recommended guidance on reporting of participant characteristics in clinical trials. It is, however, unclear how much these are adhered to in trials assessing people with dementia. This paper assesses the reporting of medical co-morbidities and prescribed medications for people with dementia within randomised controlled trial (RCT) reports.
Original language | English |
---|---|
Pages (from-to) | 868-872 |
Number of pages | 5 |
Journal | Age and Ageing |
Volume | 43 |
Issue number | 6 |
Early online date | 19 Oct 2014 |
DOIs | |
Publication status | Published - 2014 |
Keywords
- cognitive impairment
- dementia
- co-morbidity
- older people
- systematic review
Profiles
-
Jane Cross
- Dementia & Complexity in Later Life - Member
- School of Health Sciences - Associate Professor
- Lifespan Health - Member
- Volunteering and Health and Social Care - Member
- HealthUEA - Steering Committee Member
Person: Research Group Member, Academic, Teaching & Research
-
Chris Fox
- Norwich Medical School - Honorary Professor
- Institute for Volunteering Research - Member
- Norwich Epidemiology Centre - Member
- Mental Health - Member
Person: Honorary, Research Group Member, Research Centre Member
-
Fiona Poland
- School of Health Sciences - Professor of Social Research Methodology
- Norwich Institute for Healthy Aging - Member
- Institute for Volunteering Research - Member
- Volunteering and Health and Social Care - Group Lead
- Critical Volunteering Studies - Member
- Dementia & Complexity in Later Life - Member
Person: Group Lead, Research Group Member, Research Centre Member, Academic, Teaching & Research